The type II cGMP dependent protein kinase regulates GluA1 levels at the plasma membrane of developing cerebellar granule cells  by Incontro, Salvatore et al.
Biochimica et Biophysica Acta 1833 (2013) 1820–1831
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrThe type II cGMP dependent protein kinase regulates GluA1 levels at
the plasma membrane of developing cerebellar granule cellsSalvatore Incontro a, Francisco Ciruela b, Edward Ziff c, Franz Hofmann d,
José Sánchez-Prieto a, Magdalena Torres a,⁎
a Departamento de Bioquímica, Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain
b Unitat de Farmacologia (lab. 4102), Department de Patologia i Terapèutica Experimental, Facultat de Medicina-Bellvitge, L'Hospitalet del Llobregat, 08907 Barcelona, Spain
c Department of Biochemistry, New York University School of Medicine, New York, NY 10016, USA
d EoE Forschergruppe, 923 Carvas, Technische Universität, D-80802 München, GermanyAbbreviations: AMPA, α-amino-3-hydroxyl-5-me
AMPAR, AMPA receptor; Angeli's salt, disodium
CaCMKII, Ca2+-calmodulin kinase II; cGK, cGMP-de
cGMP-dependent protein kinase type I; cGKII, cGMP-dep
CTD, C-terminus domain; DAPI, 4′,6-diamino-phenylindol
vitro; FIC, freshly isolated cells; FITC, ﬂuoresceinisoth
(hydroxyimino)-5-nitro-3E-hexenamide; GAPDH, glycera
nase; IRD, near-infrared ﬂuorescent dye; JSTX, Joro spide
L-NG-monomethyl arginine citrate; LTD, long term depress
MAP2, microtubule-associated protein 2; NASPM, 1-naph
NMDA, N-methyl-D-aspartate; NMDAR, NMDA receptor;
synthase; NO, nitric oxide; NPLA, Nω-propyl-L-arginin
tein kinase; PKC, protein kinase C; PSD-95, postsynapt
gion of interest; sGC, soluble guanylyl cyclase; siRNA
N-Tris (hydroxymethyl)methyl-2-aminoethanesulfoni
⁎ Corresponding author. Tel.: +34 913943891; fax: +
E-mail address: mitorres@vet.ucm.es (M. Torres).
0167-4889/$ – see front matter © 2013 Elsevier B.V. Al
http://dx.doi.org/10.1016/j.bbamcr.2013.03.021a b s t r a c ta r t i c l e i n f oArticle history:
Received 29 October 2012
Received in revised form 11 March 2013
Accepted 19 March 2013
Available online 29 March 2013
Keywords:




cGKIITrafﬁcking of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) is regulated by
speciﬁc interactions with other proteins and by post-translational mechanisms, such as phosphorylation.
We have found that the type II cGMP-dependent protein kinase (cGKII) phosphorylates GluA1 (formerly
GluR1) at S845, augmenting the surface expression of AMPARs at both synaptic and extrasynaptic sites. Ac-
tivation of cGKII by 8-Br-cGMP enhances the surface expression of GluA1, whereas its inhibition or suppres-
sion effectively diminished the expression of this protein at the cell surface. In granule cells, NMDA receptor
activation (NMDAR) stimulates nitric oxide and cGMP production, which in turn activates cGKII and induces the
phosphorylation of GluA1, promoting its accumulation in the plasma membrane. GluA1 is mainly incorporated
into calcium permeable AMPARs as exposure to 8-Br-cGMP or NMDA activation enhanced AMPA-elicited calcium
responses that are sensitive to NASPM inhibition. We summarize evidence for an increase of calcium permeable
AMPA receptors downstream of NMDA receptor activation that might be relevant for granule cell development
and plasticity.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
AMPA glutamate receptors (AMPARs) are hetero-tetrameric cation
channels generated by the combinatorial assembly of four subunits,
GluA1-GluA4 [1–3]. The speciﬁc properties of the channels are deﬁned
by their subunit composition and for example, the inclusion of one or
more GluA2 subunits in the channel makes it impermeable to Ca2+
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l rights reserved.differential expression of their subunits and by their number at the
cell surface, which largely depends on neuronal development [5]. The
ubiquitous expression and efﬁcient editing of GluA2within neurons en-
sure that calcium impermeable AMPARs predominate in excitatory
neurons. However, Ca2+ permeable AMPARs lacking GluA2 are tran-
siently expressed by principal neurons early in development, and they
can be assembled and incorporated into synapses under certain
conditions [6–10]. Indeed, cerebellar granule cells express all four
AMPAR subunits at early developmental stages and their expression is
increased by reducing calcium entry [11].
Besides AMPARs, cerebellar granule cells also express N-methyl-D-
aspartate (NMDA) glutamate receptors (NMDARs) [5,11]. The stimula-
tion of NMDARs is essential for the survival and differentiation of these
cells during development, which play a primary role in neuroplasticity
[12,13]. The formation of NO is one consequence of NMDAR stimulation
[14], due to the anchoring of neuronal nitric oxide synthase (nNOS) to
the NMDARs through the postsynaptic density-95 protein (PSD-95),
and calcium entry through these receptors activates nNOS. The major
physiological receptor for NO is soluble guanylyl cyclase (sGC), which
synthesizes the cGMP that can drive speciﬁc cellular responses through
the regulation ofmany proteins, including cGMP-regulated phosphodies-
terases, cGMP-gated ion channels and cGMP-dependent serine/threonine
kinases [15]. The main targets of cGMP are kinases, which can transduce
these signals to a vast array of other proteins through phosphorylation.
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been identiﬁed in mammalian tissues [16,17], as well as two splice vari-
ants of cGKI with different amino-terminal domains (cGKIα and cGKIβ)
[18,19]. In the brain, earlier studies demonstrated that the distribution
of cGKIαwas very restricted, being found primarily in cerebellar Purkinje
cells and rarely at other sites [20–23]. By contrast, cGKIImRNAwas found
in amultitude of brain regions [24]where it is strongly expressed and can
be activated by the increase in cGMP produced by NO donors [25]. Fur-
thermore, the key enzymes in cGMP metabolism and signaling are
strongly expressed in the cerebellum, which is an area of considerable
plasticity during development [26]. These enzymes are developmentally
regulated in cerebellar granule cells, and maturation of the NO system is
important for both granule cell survival and acquisition of a mature phe-
notype [27–31].
In themouse hippocampus, it was recently reported that cGKII binds
to the C-terminus domain (CTD) of GluA1 in a cGMP-dependent man-
ner, which enables cGKII to phosphorylate S845 of GluA1 and increases
the amount of GluA1 at the plasma membrane [32]. This activity of
cGKII provides a new mechanism to enhance the levels of GluA1 at
the plasma membrane, which complements the increase of GluA1 at
the cell surface induced by PKA. Because the NMDAR regulates NO pro-
duction by nNOS and hence, it controls cGMP levels and cGKII activity,
this pathway provides a novel mechanism for NMDAR and NO to con-
trol the accumulation of GluA1 at the plasmamembrane. Themolecular
mechanisms that regulate GluA1 levels at the cellular surface are com-
plex and they involve interactions with scaffolding proteins [33,34], as
well as a series of phosphorylation steps at several Ser residues in the
GluA1 CTD [35]. The CTD of GluA1 is phosphorylated at S831 by both
CaMKII and PKC [35–37], at S845 by PKA and cGKII [32,38], and at
S818 by PKC [39]. Phosphorylation of S845 in GluA1 is required, al-
though not sufﬁcient, for GluA1 synaptic insertion during LTP in the
hippocampus [40]. Moreover, phosphorylation of S845 by PKA and/or
cGKII has been shown to augment the delivery of AMPARs to
extrasynaptic sites, as well as priming the receptor for synaptic in-
sertion in hippocampal neurons [32,41,42]. Cerebellar granule cells
express cGKII and GluA1 at early developmental stages [29,10] and
hence, we have investigated whether GluA1 surface expression may
be regulated by cGKII activation in cerebellar granule cells during this
period of development.2. Materials and methods
2.1. Primary cerebellar granule neuron cultures
All procedures conducted at the Universidad Complutense, Madrid,
relating to the care of animals were carried out in accordance with
our institute's ethical guidelines for animal experiments and the regula-
tions established in the European Council Directive (86/609/EEC). Pri-
mary cultures of dissociated cerebellar neurons were established from
the cerebellum of 7-day-old (P7) male or female Wistar albino rat
pups following the protocol described previously [28]. The meninges
and blood vessels were cleaned from the cerebellum, whichwas placed
in a tube containing Papain (Worthington, Lakewood NJ, USA) and trit-
urated to isolate the granule cells. The digestion was then stopped by
adding ovomucoid solution and the cerebellar neurons were diluted
in Neurobasal A supplemented with B27 (Invitrogen, Life Technolo-
gies, Madrid, Spain), 20 mM KCl, glutamax (Invitrogen, Life Technol-
ogies, Madrid, Spain) and a stabilized antibiotic antimycotic solution
(Sigma-Aldrich, Madrid, Spain). The cells were seeded onto poly-lysine
coated coverslips and placed in 6-well tissue culture plates. The cultures
were maintained at 37 °C in a humidiﬁed incubator in 5% CO2 and after
24 h in culture, 10 μMcytosine-β-D-arabinofuranoside (Sigma-Aldrich,
Madrid, Spain) was added to restrict glial cell growth. All the experi-
ments were performed on cells that had been cultured for 7 or 9 days
in vitro (DIV).2.2. Antibodies
The antibodies used in this study were: a puriﬁed rabbit polyclonal
anti-GluA1 (Ref. PC246, Calbiochem, Millipore Ibérica, Madrid, Spain);
rabbit polyclonal anti-GluA1 (Ref. 07-660, Upstate, Millipore Ibérica,
Madrid, Spain); monoclonal rabbit anti-phospho-GluA1 (Ser845), clone
EPR2148 (Ref. 04-1073, Millipore Ibérica, Madrid, Spain); mouse anti-
GluA1-NT (N-terminus) clone RH95 (Ref.MAB2263, Millipore Iberica);
monoclonal mouse anti-synapsin I (Ref. 106 001, Synaptic Systems,
Göttingen, Germany); rabbit anti-GluA1 polyclonal antibody (Ref.
PC246, Calbiochem); monoclonal mouse anti β-tubulin, clone D66
(Ref.T0198, Sigma-Aldrich, Madrid, Spain); monoclonal mouse
anti-MAP2 (Ref. 188 101, Synaptic Systems, Göttingen, Germany),
monoclonal mouse anti β-actin clone AC15 (Ref. AM4302, Life
Technologies USA, NY).
2.3. Treatments
Cultured cells 7–9 DIVwere incubated for 1 h inHBM (NaCl 14 mM;
KCl 5 mM; NaHCO3 5 mM; NaH2PO4 1.2 mM; MgCl2 1 mM; glucose
10 mM; HEPES 10 mM; CaCl2 1.33 mM) to allow them to re-polarize
their membranes before theywere subjected to the distinct treatments:
8Br-cGMP (500 μM: BioLog, Bremen, Germany) for 20 min; NMDA
(50 μM: Ascent Scientiﬁc, Abcam Biochemicals) plus glycine (10 μM:
Scientiﬁc, Abcam Biochemicals) in a magnesium free solution for
10 min; KT5823 (2 μM: Calbiochem, Merck Chemicals, Spain), a selec-
tive inhibitor of protein kinase G, for 30 min; L-NMMA (10 μM:Cayman
Chemical, Ann Arbor, MI, USA), a relatively non-selective inhibitor of all
NOS isoforms, for 60 min; NPLA (1 μM: Cayman Chemical, Ann Arbor,
MI, USA) a potent and selective inhibitor of neuronal nitric oxide
synthase (nNOS); Angeli's salt (2 μM: Cayman Chemical, Ann Arbor,
MI, USA), a nitric oxide donor, for 10 min; FK409 (10 μM: Cayman
Chemical, Ann Arbor, MI, USA), a nitric oxide donor, for 10 min. When
KT5823 administration was combined with 8-Br-cGMP or NMDA plus
glycine, the latter was added for the last 20 or 10 min of the KT5823 in-
cubation, respectively. When L-NMMA or NPLA administration was
combined with NMDA plus glycine, the latter was added for the last
10 min of the NOS inhibitor incubation.
Similar treatmentswere used for the calcium imaging experiments, in
which AMPA (50 μM: Ascent Scientiﬁc, Abcam Biochemicals, Cambridge,
UK) and cyclothiazide (10 μM: Ascent Scientiﬁc, Abcam Biochemicals,
Cambridge, UK) were applied by perfusion over 10 s in a perfusion solu-
tion (NaCl 140 mM; KCl 15 mM; CaCl2 1.33 mM; MgCl2 1 mM; TES
10 mM; glucose 10 mM). 1-Naphthylacetylspermine trihydrochloride
(NASPM, 10 μM: Tocris Bioscience, Bristol, UK), a selective antagonist of
Ca2+ permeable AMPARs was applied along with AMPA by switching
the perfusion solution. At the end of each experiment, a KCl (50 mM) so-
lution was applied for 10 s as a control of the neurons' activity.
2.4. Real-time RT-PCR reactions
GluA1mRNAwas quantiﬁed as described previously [11], performing
real-time RT-PCR with predesigned primers and MGB probes from ap-
plied Biosystems for GluA1 (Rn00709588, lot 493728). Kits with MGB
probes to amplify rat GAPDH were used as an endogenous control
(Applied Biosystems). PCR reactions were followed in a 9800 Fast
Thermal Cycler (Applied Biosystems) with TaqMan Gold PCR re-
agents. The results are expressed as 50 − ΔCT, where ΔCT is the dif-
ference between the CT for the GluA1 ampliﬁcation curve and that
for the GAPDH ampliﬁcation curve considered as a house-keeping
control gene.
2.5. Western blotting
To assess the phosphorylation of GluA1, 7–9 DIV cerebellar granule
cells were transferred to an HBM solution for 1 h at 37 °C and then
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were then homogenized in RIPA buffer containing EDTA (5 mM), prote-
ase inhibitors and phosphatase inhibitors (Pierce, Thermo Fisher Scien-
tiﬁc Inc., Rockford, IL, USA). Equal amounts of total protein for each
sample were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) on 8 or 10% gels and transferred electro-
phoretically to nitrocellulose membranes (GE Healthcare, Barcelona,
Spain) as described previously [29]. The membranes were then probed
with the appropriate primary antibodies: rabbit polyclonal anti-GluA1
(1:1000: Upstate, Millipore), monoclonal rabbit anti-phospho-GluA1
(Ser845, 1:3000: Millipore), anti-β tubulin (1:5000: Sigma-Aldrich).
After several washes, the antibodies were detected with the corre-
sponding IRD-labeled secondary antibody diluted (1:15000: Li-Cor Bio-
sciences, Lincoln, Nebraska USA) and the blots were scanned in an
Odyssey Infrared imaging system, comparing the immunoreactive pro-
teins by measuring the ﬂuorescent intensity by densitometry. The
β-tubulin signal was used to normalize for loading differences and the
data was quantiﬁed with the Odyssey 2.0 software, normalizing the
ﬁnal results to the control.
2.6. Immunocytochemistry
Two different protocols were used to speciﬁcally label the surface
GluA1 of granule cells:
A) Cerebellar granule cells (control or transfected) were plated on
polylysine-coated coverslips at a density of 100,000 cells/
coverslip. The attached cells were rinsed twice with PBS,
ﬁxed with 4% formaldehyde in PBS for 15 min at room tem-
perature, rinsed brieﬂy with PBS twice and then blocked
with PBS containing 10% normal donkey serum for 1 h at
37 °C. The cells were then incubated overnight at 4 °C under
non-permeabilizing conditions with a rabbit anti-GluA1 antise-
rum that recognizes amino acids 271–285, corresponding to
the N-terminal domain (Calbiochem, Millipore Ibérica, Madrid,
Spain), at a dilution of 1:200 in PBS containing 5% normal donkey
serum [10]. A secondary donkey anti-rabbit Alexa Fluor 488 con-
jugated antibody (Life Technologies), was used at 1:200 to stain
surface GluA1 again under non-permeabilizing conditions. After
washing several times with PBS, the cells were permeabilized
for 6 min with 0.1% Triton X-100 in PBS and incubated for 1 h
at 37 °C with PBS containing 10% normal donkey serum and
then overnight at 4 °C with a mouse anti-MAP2 antibody (Syn-
aptic Systems, Göttingen, Germany) diluted 1:1,000 in PBS
containing 5% normal donkey serum and 0.05% Triton X-100.
The coverslips were then incubated for 1 h at 37 °C with donkey
anti-mouse Alexa Fluor 594 diluted 1:300, and following several
washes in PBS, one wash with PBS with 0.1% Triton X-100 and a
last rinse in ultrapure water, the coverslips were mounted with
prolong antifade with DAPI (Life Technologies). The cells were
viewed on a Nikon Diaphot microscope equipped with a
100 × 1.3 (NA) oil immersion ﬂuor objective, a mercury lamp
light source and ﬂuorescein or rhodamine Nikon ﬁlter sets. Im-
ages were obtained using a slow-scan CCD camera (Hamamatsu
C4880) operating at 16-bits, and the camera output was stored
on a computerized imaging system (Kinetic Imaging, Ltd.). To
control the staining and conﬁrm the speciﬁcity of the antibodies
used, the cells were incubated with the secondary antibodies
alone, in the absence of primary antibodies.
B) The cell surface GluA1 receptors were labeled by incubating
live cultures for 20 min at 37 °C with rabbit NT-GluA1
(20 μg/ml: Calbiochem, Millipore Ibérica, Madrid, Spain) in HBM
solution as described previously [32]. Cultured neurons were
then ﬁxed with 4% paraformaldehyde and stained with a rabbit
594-Alexa Fluor secondary antibody (Life Technologies) under
non-permeabilizing conditions. Cells were then permeabilizedwith 0.1% Saponin (Sigma-Aldrich) in PBS, blocked with 10%
donkey serum in PBS containing 0.05% Saponin for 1 h at 37 °C
and incubated overnight at 4 °C with mouse anti-synapsin
(Synaptic Systems; Göttingen, Germany) diluted 1:800 in
PBS containing 5% donkey serum and 0.05% Saponin. After-
wards, the cells were stained for 1 h at 37 °C with a mouse
488-Alexa Fluor polyclonal secondary antiserum (Molecular
Probes, Invitrogen) and following several washes in PBS, the
coverslips were rinsed with deionized water to remove the
salts, mounted and viewed as before.
2.7. Imaging analysis
For quantitative analysis, all the images were acquired with iden-
tical settings of brightness and contrast. For the siRNA experiments
(see Fig. 6), the ROIs (regions of interest) were selected with Igor
Pro software having established standard parameters to select only
speciﬁc antibody stained clusters. The automatic threshold with the
Isodata algorithm [43] was then used to convert the image into a binary
mask that included all the ﬂuorescence emissions above background,
and spurious ROIswere removedmanually [30]. The staining intensities
were then normalized to the MAP2 labeling (internal control for quan-
titative analysis) and used to compare signal intensities between the
control and treated cells.
In experiments where GluA1 were labeled in living neurons (see
Figs. 4 and 5), the images were processed with ImageJ and background
subtractionwas carried outwith the ImageJ plugin, based on the rolling
ball radius algorithm [44] and applying a radius of 5 pixels for all the
images. In all cases, the staining intensities of the ROIs were measured
as gray-scale values (ranging from 0 to 255) using the ImageJ software.
Similarly, the integrated density value was calculated as the sum of the
gray values of each of the different pixels deﬁned in a given ROI.
When indicated, the GluA1 cluster density was calculated by di-
viding the overall number of clusters by the whole neurite length in
each ﬁeld, measuring the total neurite length with the NeuronJ plugin
of ImageJ [45]. The total number of ROI's for each ﬁeld, corresponding
to the total number of clusters, was divided by the corresponding
total length and the result was expressed as clusters/μm.
The GluA1-Synapsin apposition analysis was performed using the
ImageJ software to make a mask for the two proteins, selecting only
the clusters that were considered to be speciﬁc and merging the two
masks. GluA1-Synapsin spots were considered to be apposed if the dis-
tance between them was smaller or equal to 1 pixel [46]. These regions
were used to determine the percentage of postsynaptic clusters apposed
to a presynapse. Quantitative ﬂuorescence data were exported from
ImageJ to Origin Pro 8 software for further analysis and presentation.
2.8. Co-immunoprecipitation
The primary antibodies used for immunoprecipitation were a: rabbit
polyclonal cGMP dependent kinase II antiserum (Antibodies-online
GmbH, Aachen, Germany); a mouse anti-GluA1-NT (N-terminus) clone
RH95 (ref.MAB2263: Millipore-Iberica), and a rabbit anti-GluA1 poly-
clonal antiserum (ref. PC246: Calbiochem). The secondary antibodies
used were horseradish peroxidase-conjugated anti-rabbit IgG or anti-
mouse IgG TrueBlot™ (1:1000: eBioscience, San Diego, CA). The proteins
recovered were resolved by SDS-PAGE on 7.5% polyacrylamide gels and
transferred to polyvinylidene diﬂuoride membranes using a semi-dry
transfer system, which were then probed with the antibody indicated
and a horseradish peroxidase-conjugated secondary antibody. The im-
munoreactive bands were visualized by chemiluminescence (Pierce)
and detected in a LAS-3000 imaging system (FujiFilm Life Science,
Woodbridge, CT). For immunoprecipitation, membranes from the rat
(P14) cerebellum were solubilized for 30 min on ice in radio immuno-
precipitation assay (RIPA) buffer (50 mM Tris-HCl [pH 7.4], 100 mM
NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.2% SDS and 1 mM
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for 30 min. and the supernatant (1 mg/ml) was processed for immuno-
precipitation, each step of which was carried out with constant rotation
at 0–4 °C. The supernatant was incubated overnight with the antibody
indicated, before 50 μl of TrueBlot™ anti-rabbit Ig IP or anti-mouse Ig
IP beads (eBioscience) were added and themixture was again incubated
overnight. Subsequently, the beads were washed twice with ice-cold
RIPA buffer, twice with ice cold RIPA buffer diluted 1:10 in TBS
(50 mM Tris-HCl [pH 7.4], 100 mM NaCl) and once with TBS, and they
were aspirated to dryness with a 28-gauge needle. Subsequently,
100 μl of SDS-PAGE sample buffer (0.125 M Tris∙HCl [pH 6.8], 4% SDS,
20% glycerol, 0.004% bromphenol blue) was added to each sample, the
immune complexes were dissociated by adding fresh dithiothreitol
(DTT, 50 mM ﬁnal concentration) and heating to 100 °C for 10 min,
and the proteins were resolved and detected as described above.
2.9. Fractionation of the cerebellum
Fourteen day old wild-type and homozygous cGKII knockout
(cGKII−/−) [47] mice were anesthetized with CO2, sacriﬁced in com-
pliance with New York University Medical Center's Institutional Ani-
mal Care and Use Committee “Principles of Laboratory Animal Care”
(NIH publication number 85-23), and the cerebellum was extracted
and rapidly frozen in liquid nitrogen. After genotyping, we puriﬁed
the brain fractions and PSDs, adapting a protocol described by Jordan
et al. [48]. The cerebella were homogenized in 1 ml of solution A
(0.32 mM sucrose, 1 mM NaHCO3, 1 mM MgCl2 and 0.5 mM CaCl2)
and part of the tissue was stored as the whole cell fraction. An aliquot
of the homogenates was diluted 1:10 (weight/volume) with solution
A and centrifuged at 1000 ×g for 10 min. The supernatant was saved,
and the pellet was re-homogenized in solution A and then further
centrifuged at 1000 ×g for 10 min. The supernatants were then
spun at 15,000 ×g for 30 min to obtain the crude P2 fraction, and
the pellet was resuspended in solution B (0.32 M sucrose, 1 mM
NaHCO3). At this time a gradient of twodifferent sucrose concentrations
was prepared (5.5 ml of 1 M sucrose on the top; 5.5 ml of 1.2 M sucrose
on the bottom), and 1 ml of the sample was layered onto this gradient
and centrifuged at 82,500 ×g for 2 h. After the ﬁrst centrifugation, the
pellet was diluted ﬁve-fold in solution B and spun at 150,000 ×g for
30 min to obtain the synaptoneurosomal fraction. Part of the pellet
was resuspended in a Tris/SDS solution at 4 °C and rocked for 30 min
before storing this synaptoneurosome fraction. The other part was
resuspended in a solution containing Triton X-100 1%, 0.32 M sucrose
and 12 mM TrisHCl to obtain the crude PSD fraction. We applied a
further 15,000 ×g centrifugation for 30 min, and the pellet resuspended
in a Tris/SDS solution (12 mMTrisHCl and 4% SDS). Finally, the proteins
were separated by SDS-PAGE, detected with the GluA1 and anti-
S845-PO4 GluA1 antibodies, then normalized to the levels of beta-actin
as a loading control and compared to the WT.
2.10. cGKII silencing
An Accell siRNA (1 μM) designed to selectively silence cGKII (target
sequence: CUUUCAAGGACAAUAAAUA) or a negative control (random
non-silencing sequence: Dharmacon, Thermo Fisher Scientiﬁc Inc.,
Rockford, IL USA) were added to the cells after 4 DIV in Accell medium
supplemented with B27 (Invitrogen, Life Technologies), 20 mM KCl,
0.5 mM glutamine and the stabilized antibiotic antimycotic solution
(Sigma-Aldrich). After 72 h, the cells were ﬁxed and immunocyto-
chemistry was performed by the same protocol used in the imaging
experiments described above. The silencing of cGKIIwas veriﬁed bymea-
suring its mRNA levels by real time PCR 24 h after transfection using the
TaqMan® Gene Expression Assay Rn00435938_m1 for cGKII (Applied
Biosystems, Life Technologies; Madrid, Spain) and Rn01775763_g1 for
GAPDH as an endogenous control, as described previously [28].2.11. Measurement of [Ca2+] in individual cerebellar granule cells
The calcium responses in individual ROIs along the dendrites were
measured according to a previously described method [10]. Cerebel-
lar granule cells were plated on polylysine-coated coverslips at a den-
sity of 100,000 cells/coverslip and they were maintained in culture for
7 DIV. In primary culture, cerebellar granule cells establish functional
excitatory contacts with other granule cells. These cells were then incu-
bated with FM1-43 dye (10 μM: Life Technologies) in high potassium
buffer (NaCl 95 mM, KCl 50 mM, CaCl2 1.33 mM, MgCl2 1 mM, glucose
10 mM and TES 10 mM [pH 7.4]) for 2 min, in order to stain synaptic
boutons. Then, they were loaded with Fura-2 acetoxy methylester
(3 μM, Fura-2 AM) for 55 min at 37 °C in TES buffer (NaCl 140 mM,
KCl 5 mM, CaCl2 1.33 mM, MgCl2 1 mM, glucose 10 mM and TES
10 mM [pH 7.4]) and stimulated as appropriate. At the beginning
of each experiment an image of FM1-43 loaded cells was taken, exci-
tation at 479-nmwas provided by amonochromator and the emitted
light was collected using a ﬂuoresceinisothiocyanate (FITC) ﬁlter.
Images were taken every second with a Nikon microscope equipped
with a Nikon 40 × 1.3 (NA) oil-immersion objective. For Fura-2 mea-
surements alternative excitation at 350-nm and 380-nmwas performed
and emitted light was collected through a band-pass ﬁlter centered at
510 nm. The video images were obtained using an iXonEM + EMCCD
camera (ANDOR™ Technology) operating at 16-bits, and the output
from the camera was stored on a computerized imaging system (Andor
Software; Belfast, Northern Ireland). The image of FM1-43 loaded cells
was used to identify the ROIs with Igor Pro software in order to create
a binary mask of randomly selected ﬁelds. This mask was superimposed
on Fura-2 images and the calcium concentration was measured in these
areas, analyzing only the regions that clearly overlap with a dendrite.
Fura-2 experimentswere analyzedusing theRatio-plus plug-in of ImageJ
software. The background of the two channels was subtracted choosing
areas not illuminated by the ﬂuorescent dye and the 350 nm/380 nm
ratio was processed and represented using Origin 8.0 software.
2.12. Statistical analysis
The data was analyzed with the Statgraphic, OriginPro 7.5 or
SigmaPlot 10 statistical software and the speciﬁc test applied in
each case is indicated in the ﬁgure legends or the text. The data is
shown as the mean ± SEM: * indicates p b 0.05; ** indicates p b 0.01;
and *** p b 0.001. ImageJ, Lucida Analyse 4 (Kinetic Imaging) and Soft
Imaging Viewer (Soft Imaging System) software were used for image
processing. The difference was considered statistically signiﬁcant when
p b 0.05 with a conﬁdence limit of 95%.
3. Results
3.1. cGKII phosphorylates GluA1 at S845 in vivo
When maintained for several DIV, rat cerebellar granule cells ex-
press GluA1 mRNA and protein (Fig. 1A), in which residues S818,
S831 and S845 are major phosphorylation sites and substrates for dif-
ferent protein kinases [35,38].When cerebellar granule cells were incu-
bated with 8-Br-cGMP (500 μM), an increase in S845 phosphorylation
was detected using a phosphopeptide-speciﬁc Ab (Fig. 1B and D). Con-
versely, incubation with KT5823 (2 μM), a cGKII inhibitor, reduced the
phosphorylation of this protein and prevented the increase produced
by 8-Br-cGMP. In none of these conditions was the total amount of
GluA1 in the cells altered. Incubation with NMDA plus glycine also en-
hanced S845 phosphorylation (Fig. 1C and E), which was similarly
abolished by pre-treating the cells with KT5823 (2 μM), conﬁrming
that NMDAR requires cGKII activity to induce the phosphorylation of
GluA1 (Fig. 1C and E). We concluded that cGKII activation under the
regulation of the NMDAR and NO leads to S845 phosphorylation in
these neurons.
Fig. 1. GluA1 is expressed in cultured cerebellar granule cells and it is phosphorylated at S845 by cGMP dependent protein kinase. (A) Expression of GluA1 (mRNA and protein)
during the development of cerebellar granule cells in culture. Total RNA was extracted from freshly isolated cells (FIC), and cells 7 and 14 DIV. Equal amounts of mRNA were
used for reverse transcription and then real time PCR reactions were performed with the speciﬁc primers described in Materials and methods. The results correspond to the
mean ± SEM of four experiments performed in triplicate and they are expressed as 50 − ΔCT. Total protein extracts (15 μg) obtained from cells 3, 7 and 14 DIV were resolved
by electrophoresis and transferred to nitrocellulose membranes, which were probed with a rabbit polyclonal anti-GluA1 N-terminal speciﬁc antiserum. (B and C) Cells were incu-
bated with the compounds indicated (see Materials and methods: NMDA implies NMDA 50 μM + glycine 10 μM). Total GluA1 was assayed with a rabbit anti-GluA1 antiserum,
phosphorylated GluA1 at S845 was assayed with a rabbit PO-S845-GluA1 antiserum and β-tubulin was used as a loading control. (D and E) The diagrams show the quantiﬁcation
of several experiments, where the phospho-speciﬁc signal was normalized to the total amount of GluA1 and the ﬁnal values were normalized to the controls.(D, Control: 1;
8Br-cGMP: 1.30 ± 0.03; KT5823: 0.79 ± 0.04; 8Br-cGMP + KT: 0.75 ± 0.08; E, Control: 1; NMDA: 1.24 ± 0.02; KT5823: 0.63 ± 0.05; NMDA + KT: 0.82 ± 0.09). The data are
represented as the mean ± SEM and analyzed with an unpaired, two-sample t test (*p b 0.05, n = 7).
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S845 was modiﬁed in the cerebellum of homozygous cGKII knockout
mice (cGKII-/-, KO: 47), comparing distinct cerebellar cell fractions
from wild type (WT) and cGKII−/− mice (see Materials and methods).
The amount of GluA1 was similar in the whole homogenate in bothWT and KO mice (Fig. 2A and B), whereas there was clearly less GluA1
in the P2 fraction of the KO mice. Similarly, there was a reduction in
the amount of GluA1 in the synaptoneurosome and PSD fraction from
the KO mice (Fig. 2A and B), which was probably responsible for the
small reduction in S845-GluA1 phosphorylation observed in these
Fig. 2. Reduced GluA1 in the synaptic fraction of cGKII KO (cGKII−/−) mice. Subcellular
fractions of the cerebellum from 14 day old WT and cGKII−/−- mice were analyzed in
immunoblots. P2: crude membranes; syn: synaptoneurosome; PSD: postsynaptic den-
sity. (B) Quantiﬁcation of GluA1 immunoreactivity normalized to β-actin and ﬁnally, to
WT values (*p b 0.05, n = 3). (C) Cerebellar fractions probed in immunoblots with a
rabbit PO-S845-GluA1 antiserum. (D) Quantiﬁcation of GluA1 phosphorylation in the
synaptoneurosomal and crude PSD fractions. (E). Ratio between the phosphorylated
and total GluA1 in the synaptic fractions. Data are presented as the mean ± SEM and
analyzed using unpaired, two-sample t test (n = 3; *p b 0.05).
Fig. 3. Co-immunoprecipitation of GluR1 and cGKII from the rat cerebellum. Solubilized
extracts of the rat (P14) cerebellum were immunoprecipitated using a mouse anti-ﬂag
antibody (2 μg, lane 1), rabbit anti-cGKII polyclonal antiserum (2 μg, lane 2), rabbit
anti-HA antiserum (2 μg, lane3), a rabbit anti-GluA1 polyclonal antiserum (2 μg, lane
4) or a mouse anti-GluA1 monoclonal antibody (2 mg, lane 4 of cGKII IB). Extracts
(Crude) and immunoprecipitates (IP) were analyzed in immunoblots probed with a
rabbit anti-GluA1 polyclonal antiserum (1 μg/ml) and rabbit anti-cGKII (1 μg/ml) anti-
serum. HRP-conjugated anti-rabbit IgG and anti-mouse TrueBlot™ (1:1000) antibodies
were used as secondary antibodies to avoid IgG cross-reactivity. The immunoreactive
bands were visualized by chemiluminescence.
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in all the subcellular fractions analyzed (Fig. 2E).
3.2. Interaction of GluA1 and cGKII in cerebellar membranes
To assess the physiological relevance of the interaction between
GluA1 and cGKII, co-immunoprecipitation experiments were performed
on rat (P14) cerebellar homogenates. The anti-GluA1 antibody
immunoprecipitated a protein of around 100 kDa from soluble cerebel-
lum extracts that as demonstrated previously [32], corresponded to
GluA1 (Fig. 3, IB: anti-GluA1, lane 4). Similarly, an anti-cGKII antibody
immunoprecipitated a protein of around 85 kDa that appeared to corre-
spond to cGKII (Fig. 3, IB: anti-cGKII, lane 2: 32). Moreover, the
anti-GluA1 antibody was able to co-immunoprecipitate cGKII (Fig. 3,
IB: anti-cGKII, lane 4) from these extracts and the anti-cGKII antibody
GluA1 (Fig. 3, IB: anti-GluR1, lane 2). These protein bands were not
evident when an irrelevant mouse or rabbit IgG was used forimmunoprecipitation (Fig. 3, lanes 1 and 3, respectively), conﬁrming
the speciﬁcity of the reaction. Accordingly, these results suggest that
GluA1 and cGKII might assemble into stable protein–protein complexes
in the rat cerebellum, which survive the conditions required for solubi-
lization and co-immunoprecipitation, suggesting that these oligomeric
complexes might be physiologically relevant in vivo.3.3. Activation of cGKII augments the GluA1 at the cell surface
Exposing granule neurons in culture to 8-Br-cGMP (500 μM)
caused a signiﬁcant increase in the density of GluA1 clusters at the cell
surface (cluster/μm length of dendrite), from 0.27 ± 0.012 in control
cells to 0.36 ± 0.016 (p b 0.01: Fig. 4A and B). This increase was
prevented by preincubation with KT5823 (2 μM, added 10 min before
8-Br-cGMP; 0.18 ± 0.014: Fig. 4A andB), suggesting that cGKIImediates
the cGMP-dependent accumulation of GluA1 at the plasma membrane.
Moreover, the mean ﬂuorescence intensity of the clusters was also
greater in cells treated with 8-Br-cGMP (control: 22.50 ± 0.55 a.u.;
8-Br-cGMP: 29 ± 0.74 a.u., p b 0.01), although both the surface GluA1
cluster density (0.19 ± 0.02) and the mean labeling intensity (15 ±
0.32 a.u.) decreased signiﬁcantly when these neurons were incubated
with KT5823 (2 μM: Fig. 4A, B and C), again indicating that this signaling
pathway is active in control conditions [29]. Taken together all these re-
sults indicate that the phosphorylation of S845 is required for the
cGMP-dependent increase in GluA1 surface expression.
Since PKA increases surface GluA1 only at extrasynaptic sites [41,42],
we assayed the surface location of GluA1 following 8-Br-cGMP applica-
tion to determine if cGKII produces a similar effect.Wemeasured synap-
tic GluA1 by quantifying the proportion of GluA1 clusters apposed to the
synaptic marker, synapsin I (seeMaterials andmethods). In control con-
ditions, surface 22 ± 0.43% of GluA1 clusters were apposed to synapsin I
(Fig. 4C) and 8-Br-cGMP did not change the percentage of synaptic
GluA1 puncta apposed to synapsin I (22 ± 0.74%; p > 0.05: Fig. 4C).
Neither the density nor the intensity of the synapsin I posive puncta
changed in any of the experimental conditions (results not shown).
Since the total GluA1 positive cluster increased in cells incubated with
8-Br-cGMP, although the percentage of apposition was equal the abso-
lute value also increased. These results indicate that the new receptors
are likely to be incorporated into both synaptic and extrasynaptic areas
of the membrane. Conversely, a reduction in plasma membrane GluA1
was induced in the presence of KT5823, as there was a clear reduction
in the GluA1 clusters apposed to synapsin I both in control conditions
and in cells treated with 8-Br-cGMP (15.6 ± 0.49%; p b 0.05).
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increase in GluA1 cluster density and intensity similar to that pro-
duced by 8-Br-cGMP (Fig. 5A and B). Moreover, KT5823 reduced
this increase in cluster density, counteracting the effect of NMDA. In-
deed, while the slight increase in the intensity of GluA1 puncta pro-
duced by NMDA was reduced by KT5823 (Fig. 5D), NMDA did not
modify the percentage of GluA1 positive puncta apposed to synapsin
I, although KT5823 did reduce this parameter (Fig. 5C).
We assumed that the cGMP-dependent activation of GKII depends
on NO produced by NOS upon NMDA receptor activation. In order toFig. 4. Activation of cGKII by cGMP causes an increase of cellular surface GluA1. (A) Cerebell
incubation with 8Br-cGMP (500 μM) for 20 min or inhibition with KT5823 during 30 min fo
Materials and methods. Images represent the immunostaining for synapsin I and GluA1, the
dendrites (clusters/μm). ROI's of the speciﬁc antibody were selected for each condition fro
clusters apposed to synapsin I puncta, either upon stimulation or inhibition (n = 30 ﬁelds fr
rescence intensity (mean values: control 19.4 ± 0.06; 8Br-cGMP 23.1 ± 0.11; KT5823 16.4
mean ± SEM and analyzed with an unpaired, two-sample t test (*p b 0.001). The Komolgomore directly conﬁrm that, we analyzed whether two different NOS
inhibitors (L-NMMA and NPLA) were able to abolish the effect of
NMDA receptor activation on plasma membrane GluA1 increase. As
shown in Supplementary Fig. S1 these two inhibitors suppressed the
NMDA effect and also reduced the control values as KT5823 did. On
the other hand, when cells were incubated for ten minutes with either
10 μMFK-409 or 2 μMAngeli's salt the cell surface GluA1 immunoreac-
tivity increased (Fig. S2). These results conﬁrm the involvement of NO
in the NMDA stimulated signaling that triggers GluA1 phosphorylation
and incorporation into plasma membrane.ar granule cells maintained for 8 DIV were subjected to different treatments as shown:
llowed by incubation with a GluA1-NT antibody (20 μg/ml) for 20 min as indicated in
merged image and an ampliﬁcation of each condition. (B) Density of GluA1 clusters in
m at least 15 ﬁelds from 2 different experiments. (C) Analysis of the fraction of GluA1
om 2 independent experiments). (D) Cumulative probability plots for GluA1 mean ﬂuo-
± 0.03; 8Br-cGMP + KT 16.7 ± 0.06, a.u.). In B and C the data are presented as the
rov–Smirnov test was used for the cumulative probability. Scale bars: 10 μm.
Fig. 5. NMDA dependent production of NO causes GluA1 accumulation at plasma membrane. (A) Cerebellar granule cells maintained for 8 DIV were treated for 10 min with NMDA
(50 μM) + glycine (10 μM), or for 30 min with KT5823, followed by incubation with a GluA1-NT antibody (20 μg/ml) over 20 min. The images represent the immunostaining of
synapsin I and GluA1, the merged image and an ampliﬁcation of each condition. (B) The density of GluA1 clusters in dendrites (clusters/μm), selecting ROI's of the speciﬁc antibody
from at least 15 ﬁelds from 2 different experiments for each condition. (C) Analysis of the fraction of GluA1 clusters apposed to synapsin I puncta, either upon stimulation or
inhibition (n = 30 ﬁelds from two independent experiments with different cell cultures). (D) Cumulative probability plots of GluA1 mean ﬂuorescence intensity (mean values:
control 19.7 ± 0.04; 8Br-cGMP 23.4 ± 0.08; KT5823 16.2 ± 0.06; 8Br-cGMP + KT 16.9 ± 0.07, a.u.). In B and C, the data are represented as the mean ± SEM and analyzed
using unpaired, two-sample t test (*p b 0.001). For the cumulative probability the Komolgorov–Smirnov test was used. Scale bars: 10 μm.
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Cerebellar granule cells were transfected with a speciﬁc siRNA to
silence cGKII, which effectively reduced the amount of cGKII mRNA
to 22 ± 0.003% that of the control levels 48 h after transfection (as
determined by real time PCR). There was a clear reduction in plasma
membrane GluA1 in these cells (Fig. 6A, B and C), without any change
in total GluA1 or GluA4 (results not shown). The non-silencing siRNA
used as a control did not modify the levels of GluA1 in the membrane,ruling out any non-speciﬁc effects of siRNA transfection. Moreover,
the labeling of MAP2, used as an internal labeling control, did not
change in any of the experimental conditions (Fig. 6D).
3.5. The surface increase in GluA1 is accompanied by an increase in calcium
permeable AMPARs
To examine whether the increase in GluA1 subunits at the plasma
membrane affected the response to AMPA stimulation, we measured
Fig. 6. cGKII silencing decreases GluA1 surface expression. Cerebellar granule cells at 5 DIV were transfected with the cGKII siRNA and immunostained at 8 DIV with the speciﬁc
rabbit NT-GluA1 antiserum and a mouse anti-MAP2 antibody. (A) Representative images of GluA1/MAP2 immunolabelling in control (scrambled siRNA) and cGKII silenced cells.
(B and E) Cumulative probability plots and bar chart for the GluA1/MAP2 mean ﬂuorescence intensity (**p b 0.001, Mann–Whitney and Kolmogorov–Smirnov tests): Control
878 ROIs 0.27 ± 0.07; scrambled siRNA 3365 ROIs 0.26 ± 0.03; cGKII siRNA 2716 ROIs 0.06 ± 0.01. (D) Cumulative probability plots of the mean MAP2 ﬂuorescence intensity
(a.u.) of cells also labeled with anti-GluA1 (MAP2 mean intensity 60.7 ± 0.54, 58.7 ± 1, 59.2 ± 1.5 for control, scrambled siRNA and cGKII siRNA respectively: p > 0.05, Mann–
Whitney and Kolmogorov–Smirnov tests).
1828 S. Incontro et al. / Biochimica et Biophysica Acta 1833 (2013) 1820–1831the AMPA-elicited calcium increases in cell processes. Since FURA2-AM
produces homogeneous labeling and in order to analyze calcium
responses in discrete regions, we labeled synaptic boutons at the be-
ginning of the experiment with the styryl dye FM1-43. After washing
off the excess dye, a picture was obtained (Fig. 7A) to use as a mask
that could be superimposed onto the FURA-2 images and that served
to analyze the calcium responses in dendritic ROIs the nearest possible
to the synapses. Taking advantage of the selective blockage of calcium
permeable AMPARby 1-naphthyl acetyl spermine (NASPM), a synthetic
analog of Joro spider toxin (JSTX), we analyzed the contribution of cal-
cium permeable AMPARs to each individual response in these regions.
Different responses were observed in terms of the capacity of NASPM
toblock the increase in calciumelicited by AMPA (Fig. 7B). The responseFig. 7. The [Ca2+] in individual cerebellar granule cells. (A) Scheme of the experiment and
obtained from the FM1-43 image (scale bar: 10 μm). (B) Representative AMPA elicited calci
1st stimulus), AMPA (50 μM) + cyclothiazide (10 μM) in the presence of NASPM (10 μM
(C) Δ(F/F0) of the AMPA response for each condition expressed as the mean ± SEM (contr
NMDA, 341 ROIs from 5 experiments; KT5823, 817 ROIs from 9 experiments; 8Br + KT, 315
ROIs from 4 experiments; cGKII KD + KT, 882 ROIs from 4 experiments). (D) Δ(F/F0) of th
analyzed from 2 experiments; NMDA, 140 ROIs from 2 experiments; L-NMMA, 130 ROIs fr
from 2 experiments; NPLA + NMDA, 108 ROIs from 2 experiments). (E) Cumulative proba
calcium responses in the different experimental conditions (p b 0.05, Kolmogorov–Smirno
NASPM of the AMPA-induced calcium responses in the different experimental conditio
mean ± SEM and the statistical signiﬁcance was analyzed using an unpaired, two-sampleto AMPA (50 μM) plus cyclothiazide (10 μM) was enhanced by pre-
treatmentwith 8-Br-cGMP or NMDA in 72% and 55% of the ROIs respec-
tively, while it decreased in the presence of the cGKII inhibitor, KT5823
or NOS inhibitors (Fig. 7C and D). A dampened response to AMPA was
also observed in cGKII knockdown cells and in these cells, KT5823 did
not produce any additional effect (Fig. 7C). In cells in which the AMPA
response was increased by exposure to 8-Br-cGMP or NMDA, the in-
crease in calcium elicited by AMPA was almost completely inhibited
by NASPM (Fig. 7E and F). Conversely, in cells preincubated with either
the cGKII inhibitor or NOS inhibitors or in which cGKII was silenced,
conditions in which GluA1 subunits are removed from the plasma
membrane, the inhibition produced by NASPM was clearly diminished
(Fig. 7E and F).representative pictures showing Fura 2-AM, FM1-43 ﬂuorescence and the binary mask
um responses and their inhibition by NASPM: AMPA (50 μM) + cyclothiazide (10 μM:
: 2nd stimulus), and KCl (50 mM) used as a control of depolarization (3rd stimulus).
ol, 1363 ROIs analyzed from 9 experiments; 8Br-cGMP, 823 ROIs from 6 experiments;
ROIs from 6 experiments; NMDA + KT, 454 ROIs from 5 experiments; cGKII KD, 1138
e AMPA response for each condition expressed as the mean ± SEM (control, 220 ROIs
om 2 experiments; NMDA + L-NMMA, 145 ROIs from 2 experiments; NPLA, 200 ROIs
bility plots of the percentage of inhibition produced by NASPM of the AMPA-induced
v tests). (F) Cumulative probability plots of the percentage of inhibition produced by
ns (p b 0.05, Kolmogorov–Smirnov tests). Data from C and D are presented as the
t test and one way ANOVA followed by Bonferroni's test (*p b 0.05).
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We show here that cGKII phosphorylates GluA1 at S845 in cere-
bellar granule cells, thereby enhancing its insertion into the plasma
membrane and the formation of functional calcium permeable recep-
tors sensitive to NASPM. Moreover, stimulation of the NMDARactivates cGKII, also increasing GluA1 phosphorylation and its plasma
membrane insertion. Notably, a cGKII siRNA that effectively silenced
the production of cGKII mRNA reduces the GluA1 in the plasma mem-
brane, and in the cerebellar PSD fraction of cGKII KO mice, less S845
pGluA1 and total GluA1 accumulates than in the same fraction of
WT mice. Moreover, the co-immunoprecipitation of GluA1 and cGKII
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these proteins might assemble into stable complexes in the rat cerebel-
lum, as described in hippocampus [32]. Since we did not stimulate
cGMP production in our preparation, our results are consistent with
the constitutive presence of this complex and that the cGKII activation
would probably lead to the phosphorylation of GluA1 and its incorpora-
tion into the plasmamembrane. These results demonstrate the existence
of a GluA1 trafﬁcking pathway regulated byNOand cGKII that leads to an
increase in calcium permeable AMPARs at the cell surface and, as a con-
sequence, enhanced Ca2+ entry in response to cell stimulation.
The enhancement of GluA1membrane insertion by NMDA-NO-cGKII
signaling has been demonstrated previously in hippocampal and cortical
neurons, where there is evidence that this mechanism is relevant in
LTP [32]. An important mechanism underlying NMDAR-dependent
LTP involves the insertion of GluA1 into synapses [49,50] and while
S845 phosphorylation by cGKII enhances the insertion of GluA1
into the membrane at extrasynaptic sites, this may prime the system
for subsequent potentiation by a tetanic stimulation [32]. Converse-
ly, it has also been shown that activation of the NO-cGMP-cGKI path-
way increases both GluA1 and synaptophysin puncta in
hippocampal neurons, suggesting that such signaling can act presyn-
aptically and postsynaptically to form new synaptic contacts [51].
There is growing evidence of a signiﬁcant overlap between signaling
pathways involved in differentiation at early developmental stages and
those that later mediate plasticity in mature neurons [52,53]. Because
cerebellar granule cells express GluA1 early in development, this mech-
anism might help strengthen existing connections or the formation of
new ones during the functional development triggered by NO and
cGMP. In this sense, both 8-Br-cGMP and NMDA induce an increase in
the density of synapsin puncta [30] and GluA1 clusters, effects that are
counteracted and reversed by KT5823. The increase in cluster density
was accompanied by an increase in immunoﬂuorescence intensity com-
patible with the presence of more protein in these clusters, while con-
versely, the reduced cluster density provoked by exposure to KT5823
was accompanied by a reduction in their mean ﬂuorescence. In 7 DIV
cerebellar granule cells, GluA1 is mainly located extrasynaptically since
less than 25% of GluA1 clusters are juxtaposed to synapsin puncta. Both
8-Br-cGMP and NMDA increased the GluA1 cluster apposed to synapsin
I positive puncta although they did not augment the percentages, how-
ever KT5823 signiﬁcantly diminished the proportion of GluA1 clusters
juxtaposed to synapsin puncta. Hence, S845 dephosphorylation caused
a loss of plasma membrane GluA1, a reduction that may also occur in
synapses. S845 is dephosphorylated during hippocampal LTD where
the removal of GluA1 containing AMPAR from synapses occurs [54].
Moreover, in the cGKII KO mouse there is less S845-pGluA1 in the PSD
fraction than inWT mice, which reﬂected a reduction in total GluA1. Al-
though GluA1-S845 is also a substrate for PKA [38], the results presented
here indicate that cGKII plays a central role in regulating the level of
GluA1 at synapses in the cerebellum.
Calcium permeable AMPARs are expressed early in development
[55,56] and although their role has yet to be fully elucidated, it has
been suggested that they may mediate localized and regulated
Ca2+ entry that is pivotal in the development andmaturation of neu-
rons [56–58]. The presence of calcium permeable AMPARs in the
membrane of granule neurons and their up-regulation by cGKII acti-
vation might contribute to the activity- and NO-dependent survival
and differentiation of neurons [28–31,59]. The role of the NO-cGMP
pathway in cerebellar development and function has been ﬁrmly
demonstrated. The activity-dependent maturation of granule cells
in vivo is triggered by mossy ﬁber inputs [60] and mossy ﬁber stimu-
lation causes a signiﬁcant NMDAR- and NOS-dependent release of
NO in the granular layer of rat cerebellar slices [61]. NO synthesized
downstream of NMDAR activation plays a central role in neuronal ac-
tivity, mediating important events like neurotransmitter release,
activity-dependent survival and long-term potentiation [13,62,63].
Since NO is a diffusible signal, it may not only affect the synapse whereit is produced but also, neighboring synapses and cells [64]. In culture,
cerebellar granule cells establish synapseswith themselves and their de-
velopment is also affected by the NO and cGMP pathway.While NO neg-
atively regulates precursor proliferation through a cGMP-independent
mechanism [65], it also triggers differentiation and maturation by a
cGMP-dependent one [30,31,66].
In summary, our data clearly demonstrate that at early developmen-
tal stages, cGKII regulates calcium permeable AMPAR density at the
plasmamembrane of cerebellar granule cells through the phosphoryla-
tion of S845 from GluA1. It remains to be elucidated to what extent this
mechanism is relevant for the development and maturation of these
cells.
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